Synflorix is a vaccine designed to protect against infections caused by Streptococcus pneumoniae, a bacterium responsible for a range of serious diseases such as pneumonia, meningitis, and sepsis, particularly in children and the elderly. It is a pneumococcal conjugate vaccine (PCV) that works by stimulating the body's immune system to produce antibodies against pneumococcal bacteria, offering protection against several serotypes of the bacterium. Synflorix is commonly administered in early childhood according to local immunization schedules, and it plays a crucial role in public health efforts to reduce the incidence of pneumococcal diseases globally. The vaccine's composition allows it to be effective in preventing diseases caused by multiple strains of Streptococcus pneumoniae, making it a key tool in the fight against bacterial infections that can lead to severe health complications and fatalities.